Showing results (991-1000 of 1,186) with videos related to
Sort By:
Pageof 119
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2023
Characterization of Selective M5 Acetylcholine Muscarinic Receptor Modulators on Dopamine Signaling in the StriatumVivien Zell, Greetje Teuns, Alexandra Stormy Needham, et al.Breast Cancer Research and Treatment|August 2, 2003
A phase II study of topical ceramides for cutaneous breast cancerAminah Jatoi, Vera J Suman, Paul Schaefer, et al.Occupational Medicine (Philadelphia, Pa.)|April 1, 1995
Mortality patterns among construction workers in the United StatesC F Robinson, W E Halperin, T Alterman, et al.Molecular Genetics & Genomic Medicine|May 27, 2017
The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancersDeirdre Weymann, Janessa Laskin, Robyn Roscoe, et al.Psychological Medicine|November 13, 2020
Functional connectivity associated with improvement in emotion management after cognitive enhancement therapy in early-course schizophreniaSynthia Guimond, George Ling, Jessica Drodge, et al.The Journal of Investigative Dermatology|September 1, 1987
An autoantibody in pemphigus serum, specific for the 59 kD keratin, selectively binds the surface of keratinocytes: evidence for an extracellular keratin domainL A Diaz, S A Sampaio, C R Martins, et al.Cancer|December 18, 2008
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047ADomingo G Perez, Vera J Suman, Tom R Fitch, et al.Plos One|May 26, 2017
Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in humanJulian Krauskopf, Theo M de Kok, Shelli J Schomaker, et al.Stroke|February 2, 2002
Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacementDavid F Moore, Gheona Altarescu, Geoffrey S F Ling, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey A Sloan, Daniel J Sargent, et al.Pageof 119